Eckert & Ziegler SE (LON:0NZY)
14.88
-0.12 (-0.80%)
At close: Dec 16, 2025
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 75.31M EUR in the quarter ending September 30, 2025, with 7.42% growth. This brings the company's revenue in the last twelve months to 304.47M, up 9.63% year-over-year. In the year 2024, Eckert & Ziegler SE had annual revenue of 295.85M with 20.22% growth.
Revenue (ttm)
304.47M EUR
Revenue Growth
+9.63%
P/S Ratio
3.06
Revenue / Employee
280.62K EUR
Employees
1,085
Market Cap
812.65M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
| Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
| Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
| Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
| Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |